Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
Clinical trial NCT02933788 · UNKNOWN
Trial details
- NCT number
- NCT02933788
- Sponsor
- Kangbuk Samsung Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2016-12-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.